anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Alexion Pharmaceuticals, Inc. (ALXN) · page 2 of 10

The slide uses a combination of a line chart for valuation erosion and bar charts for relative performance benchmarking.

Shareholder letter · peer_gap · expose_gap · dense density

Deck inventory Unlock
More
Slide JSON Deck JSON
Slide locked Sign in to view
Slide schematic 6/6
chart 3/3 paragraph 1/1 source-note 1/1 title 1/1
Components 6
bar-grouped bar-vertical line paragraph source-note headline
Tools 2
Chart Selection Guide slide · 50%

chart/bar-vertical: Total Shareholder Return over ALXN Chairman Tenure (%)

 Slide recipe: the peer-gap chart slide · 70%

Indeed, during your tenure, Alexion is the worst performer across the broader large-cap biopharma sector.
Metrics 0
∅
No metrics

No metric insight is anchored to this slide.

Frameworks 1
comparison_frame 90%

Comparing Alexion's performance against peers and indices to highlight underperformance.